Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared surgery blood reserve reduces surgery suspension rate due to blood unavailability. | Transfus Apher Sci | 2022 | 34772628 | PubTator, text mining | PubMed |
| Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma. | Mol Cancer Ther | 2022 | 34737198 | PubTator, text mining | PubMed |
| Preventing alloimmunization using a new model for matching extensively typed red blood cells. | Vox Sang | 2022 | 34725840 | PubTator, text mining | PubMed |
| Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products. | Vox Sang | 2022 | 34699082 | PubTator, text mining | PubMed |
| Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic. | Transfus Apher Sci | 2022 | 34690073 | PubTator, text mining | PubMed |
| SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread. | Transfus Apher Sci | 2022 | 34686444 | PubTator, text mining | PubMed |
| SARS COV-2- IgG antibodies in blood donors in pandemic - A game changer for policy makers. | Transfus Clin Biol | 2022 | 34653615 | PubTator, text mining | PubMed |
| Molecular blood group screening in Omani blood donors. | Vox Sang | 2022 | 34647328 | PubTator, text mining | PubMed |
| SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia. | Cancer Discov | 2022 | 34531253 | PubTator, text mining | PubMed |
| Practices for RhD alloimmunization prevention: a vignette-based survey of midwives. | J Matern Fetal Neonatal Med | 2022 | 34433367 | PubTator, text mining | PubMed |
| Platelet transfusion practice and related transfusion reactions in a large teaching hospital. | Transfus Clin Biol | 2022 | 34411746 | PubTator, text mining | PubMed |
| Effects of message framing on recruiting Rh-D-negative blood donors in an emergency situation: Two randomized trials. | Br J Health Psychol | 2022 | 34337827 | PubTator, text mining | PubMed |
| The efficacy of ethnic specific blood groups genotyping for routine donor investigation and rare donor identification in Taiwan. | Vox Sang | 2022 | 34159602 | PubTator, text mining | PubMed |
| Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)-positive blood products to Rh(D)-negative children. | Vox Sang | 2022 | 34159595 | PubTator, text mining | PubMed |
| Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations. | Vox Sang | 2022 | 34155647 | PubTator, text mining | PubMed |
| A comparative study on perinatal outcomes of red blood cell-alloimmunized pregnancies with anti-RhD in combination and anti-RhD alone in China. | Vox Sang | 2022 | 34111300 | PubTator, text mining | PubMed |
| Frequency of Rh and K antigens in blood donors in Riyadh. | Hematol Transfus Cell Ther | 2022 | 33992594 | PubTator, text mining | PubMed |
| Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience. | Blood Transfus | 2022 | 33819144 | PubTator, text mining | PubMed |
| Frequency of antigen Dia on the blood donor population of the Hemocenter coordinator of the Hemopa Foundation. | Hematol Transfus Cell Ther | 2022 | 33773956 | PubTator, text mining | PubMed |
| High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited setting. | Hematol Transfus Cell Ther | 2022 | 33744228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=51